National Defense Medical Center

Giant Force Technology Corporation

Chi-Hong Chu

Wen-Liang Chang

An-Rong Lee

Chen-Wen Yao

Wen-Hsin Huang

Ann Chen

Kuo-Yuan Hwa

Li-Heng Pao

Chiao-Ying Chien

Chien-Yi Pai

The present invention relates to a use of mycophenolate mofetil or a pharmaceutically acceptable salt thereof in the manufacture of a medicament against influenza virus. The present invention also relates to a use of mycophenolate mofetil or a pharmaceutically acceptable salt thereof in the manufacture of a medicament against drug-resistant influenza virus strains. The present invention is further related to a method for treating influenza in a subject, comprising administering to said subject an effective amount of mycophenolate mofetil or a pharmaceutically acceptable salt thereof.

Usage of mycophenolate mofetil or salt thereof in preparing drug for resisting against influenza virus

Disclosed are an Schisandrae fructus extract for inhibition or prevention of influenza and its application, wherein the Schisandrae fructus extract is obtained by water, methanol, or ethanol extraction process and the extract comprises compounds such as schisandrone, benzoylgomisin P, wulignan A1, epigomisin O, epiwulignan A1, and tigloylgomisin P. The extracts and purified compounds of Schisandrae fructus has anti-influenza virus H1N1 and H1N1-TR (a Tamiflu drug resistant virus strain) activities, therefore the extracts and the purified compounds of Schisandrae fructus can be applied as an inhitibory agent of a pharmaceutical composition for treatment or prevention agent for influenza infection.

[object Object]

Growing community of inventors

Taipei, Taiwan

Chi-Hong Chu